EXEL
Exelixis Inc
$54.95
0.13 (0.24%) Today
0.54 (0.99%) After-hours
— up— down
Market Cap
$13.68B+23.4%
Revenue (TTM)
$2.23B+7.9%
Net Income (TTM)
$758.40M+64.0%
EPS (TTM)
3.02+64.0%
Shares Out
251.36M
251.36MP/E Ratio
16.43
16.43Forward P/E
14.88
14.88Open
$54.71
$54.71Previous Close
$54.28
$54.28Day Range
$54.00 – $54.88
$54.00 – $54.8852-Week Range
$33.76 – $55.91
$33.76 – $55.91Beta
0.43
0.43Volume
2.60M
2.60MAvg Volume
2.78M
2.78MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout EXEL
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.